Capricor Therapeutics
CAPR
#7980
Rank
โ‚น26.15 B
Marketcap
โ‚น572.16
Share price
-4.36%
Change (1 day)
-51.67%
Change (1 year)

Capricor Therapeutics (CAPR) Fails to deliver data

Key failure to deliver metrics for Capricor Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Capricor Therapeutics (CAPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Capricor Therapeutics (CAPR) - since 2019

Volume in USD (price x number of shares), data since 2019

Capricor Therapeutics (CAPR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚น0.11 B77.82%
2024โ‚น61.89 M1584.06%
2023โ‚น3.67 M24.67%
2022โ‚น2.94 M-49.93%
2021โ‚น5.88 M-88.57%
2020โ‚น51.49 M573.14%
2019โ‚น7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Cytokinetics
CYTK
โ‚น13.15 Mโ‚น35.16 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚น0.2 Mโ‚น0.26 M๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น57.52 Mโ‚น0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น2.78 Mโ‚น30.57 M๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น6.39 Mโ‚น11.98 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/Aโ‚น2.03 M๐Ÿ‡บ๐Ÿ‡ธ USA